Friday Favorites Epigenetic Clocks for Testing Your Biological Age
Watch on YouTubeVideo summary
The video explores how epigenetics, specifically the process of methylation, serves as a fundamental mechanism that determines cell identity and function throughout life. Although every cell in our body contains the same DNA, chemical markers known as methyl groups silence specific genes to ensure a heart cell remains a heart cell rather than turning into skin or kidney cells. While this maintenance system is highly accurate, retaining fidelity between 97% and 99.9% with each cell division, it is not perfect. Over time, these tiny errors accumulate, causing the epigenetic patterns of identical twins to drift apart as they age, which explains why they may develop different diseases or experience health issues at different times despite sharing the same genetic code.
Building on this understanding, scientists have developed "epigenetic clocks" that act as molecular crystal balls capable of predicting human aging with remarkable precision. By analyzing specific DNA sites that reliably gain or lose methylation markers as we grow older, researchers can estimate a person's age within just a few years by measuring only a small subset of these sites. These clocks have emerged as superior predictors of biological age compared to traditional methods like telomere length measurement. Unlike simply counting birthdays, these clocks measure true biological age, reflecting the cumulative impact of lifestyle choices, diet, and environmental factors on how quickly our bodies are actually aging.
The implications of this technology extend far beyond curiosity, offering critical insights into healthspan and longevity that could revolutionize medicine and insurance. If an individual's epigenetic clock indicates they are biologically older than their chronological age—a condition known as epigenetic age acceleration—it signals that they are aging too fast and faces a significantly higher risk of mortality and age-related diseases such as Alzheimer's, Parkinson's, frailty, and arthritis. For instance, a 50-year-old with an accelerated clock might have the biological markers of a 60-year-old, suggesting they may only have twenty years left instead of the expected thirty. This data could eventually lead to personalized health assessments where insurance premiums are based on biological rather than calendar age, though it also opens the door for tracking the effectiveness of anti-aging interventions.
Ultimately, the discovery of epigenetic clocks offers a hopeful perspective because aging is not an unchangeable fate set in stone like a gypsy fortune teller's curse. Since these markers respond to our daily habits and environment, individuals can actively influence their rate of aging through diet and lifestyle modifications. In the near future, these clocks may provide a rapid and affordable method for testing various anti-aging strategies, allowing people to monitor their progress in real-time. By understanding that our biological age is dynamic rather than fixed, we gain the power to make informed choices that could potentially slow down the aging process and extend both our healthspan and lifespan.
Read the full video transcript
My book, How Not to Age, all about the
mechanisms of aging and how we can
affect them through diet and lifestyle,
can looking at epigenetics, modifiers of
gene expression, help predict our health
span and lifespan? Watch to find out.
>> [music]
>> Epigenetics, the differential expression
of genes, both establishes the character
and function of a cell and maintains
that identity over time through round
after round of cell division. So, a
heart cell stays a heart cell and
divides to make more heart cells instead
of skin cells or kidney cells, even
though all of our main cells have the
same entire complement of DNA to
potentially be anything.
This is accomplished by methylation,
chemical markers that silence
inappropriate genes in a particular
cell.
The fidelity of that maintenance of
methylation is good, 97% to 99.9% every
division, but not perfect. Over time,
those tiny errors may add up and may
help explain why the methylation
patterns of identical twins drift apart
as they age.
The epigenetic markers of young
identical twins are essentially
indistinguishable, but then diverge over
time. Identical twins have the same DNA,
the same genes, but the difference in
gene expression among older identical
twin pairs were found to be about four
times greater than those observed in
young pairs. This may result in them
each getting different diseases. An
age-related disease like Alzheimer's
only has an identical twin concordance
rate of about 50%, meaning if one twin
gets it, there's only about a coin flip
chance that the other will, too, despite
identical DNA.
Or even if they do both get it, the
disease may manifest decades apart.
Any epigenetic differences that may
contribute to differential disease rates
may arise from having different diets
and lifestyles
or maybe a result of random epigenetic
drift. However, there are certain DNA
sites on our chromosomes that
predictably methylate or demethylate as
we age. So predictable, in fact, it's
like clockwork.
One of the earliest attempts to study
aging in the epigenome, which is only
like a dozen years ago, found DNA from a
103-year-old
appeared to be less methylated overall
than the DNA of a newborn infant,
suggesting perhaps that aging involves a
general loss of epigenetic markings.
We now know it's more complicated than
that. Of the methylation sites that
reliably change as we age, about 60% go
from methylated to unmethylated, and the
other 40% become more methylated over
time. Some so reliably change with age
that they've been considered a molecular
crystal ball for human aging. In a
remarkable triumph of big data, out of
the millions of methylation sites on our
DNA, a tiny subset so dependably shift
over time that you can predict someone's
age within a few years just by
strategically measuring the methylation
pattern in a few hundred or even just a
few dozen sites in someone's 3 billion
letter genome.
Over just the last few years, these
epigenetic clocks have become
established as robust measures of
chronological age, surpassing telomere
length as the best age predictor.
Who cares though? I mean, why invent
some costly Rube Goldberg approach to
divining someone's age when you can
simply ask them?
Well, you can imagine forensic
applications, the determination of an
unidentified victim's age with a blood
sample.
But, that's just scratching the surface.
The kicker
is that epigenetic clocks don't just
track your chronological age, but appear
to measure your true biological age. In
other words, your epigenetic age can
better predict your remaining life
expectancy than your calendar age.
It's like science fiction. Feed a drop
of blood into some futuristic machine
that scans the placement of chemical
markers on a strand of DNA and it spits
out your true age, reflecting a lifetime
of lifestyle choices.
If the machine calculated that you have
the DNA methylation pattern of a
60-year-old, but you've only had 50
birthdays, that would be an example of
epigenetic age acceleration, when your
epigenetic clock age is older than your
actual chronological age. That would be
an indication that you're aging too
fast.
As a 50-year-old, you'd think you have
another 30 years on this earth, but
because the epigenetic clock shows that
you're aging such an accelerated pace,
it's more like you only have another 20
years left.
Every 5 years of epigenetic age
acceleration is associated with an 8 to
15% increased risk of mortality.
In addition to predicting time to death,
epigenetic clocks also appear to
foretell health span indicators such as
cognitive decline, frailty, arthritis,
and the progression of diseases like
Alzheimer's and Parkinson's.
As you can imagine, the insurance agency
has jumped on this and your premiums may
soon be determined by your epigenetic
age.
But, it's not some gypsy fortune teller
curse set in stone. You can change the
rate at which you age and may soon be
able to use epigenetic clocks to track
your progress, potentially presenting a
radically faster and cheaper way to test
anti-aging interventions.
>> Mhm.